Abstract
MK-801 was found to be more potent than phencyclidine (PCP) as an inhibitor of N-methyl-D-aspartate-induced [3H]norepinephrine (NE) release and [3H]TCP binding in the hippocampus. On the other hand, MK-801 was slightly less potent than PCP to enhance kainate-stimulated [3H]NE release and to inhibit hippocampal [3H]NE uptake. Further, MK-801 was strikingly less potent than PCP as an inhibitor of striatal synaptosomal [3H]dopamine uptake. These data are discussed with reference to the therapeutic potential of MK-801.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 223-226 |
| Number of pages | 4 |
| Journal | European Journal of Pharmacology |
| Volume | 145 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 12 1988 |
| Externally published | Yes |
Keywords
- Dopamine uptake
- MK-801
- N-Methyl-D-aspartate-induced release
- Phencyclidine
- [H]TCP
ASJC Scopus subject areas
- Pharmacology